Treatment of suicidal people around the world
- PMID: 21263012
- PMCID: PMC3167419
- DOI: 10.1192/bjp.bp.110.084129
Treatment of suicidal people around the world
Abstract
Background: Suicide is a leading cause of death worldwide; however, little information is available about the treatment of suicidal people, or about barriers to treatment.
Aims: To examine the receipt of mental health treatment and barriers to care among suicidal people around the world.
Method: Twenty-one nationally representative samples worldwide (n=55 302; age 18 years and over) from the World Health Organization's World Mental Health Surveys were interviewed regarding past-year suicidal behaviour and past-year healthcare use. Suicidal respondents who had not used services in the past year were asked why they had not sought care.
Results: Two-fifths of the suicidal respondents had received treatment (from 17% in low-income countries to 56% in high-income countries), mostly from a general medical practitioner (22%), psychiatrist (15%) or non-psychiatrist (15%). Those who had actually attempted suicide were more likely to receive care. Low perceived need was the most important reason for not seeking help (58%), followed by attitudinal barriers such as the wish to handle the problem alone (40%) and structural barriers such as financial concerns (15%). Only 7% of respondents endorsed stigma as a reason for not seeking treatment.
Conclusions: Most people with suicide ideation, plans and attempts receive no treatment. This is a consistent and pervasive finding, especially in low-income countries. Improving the receipt of treatment worldwide will have to take into account culture-specific factors that may influence the process of help-seeking.
Conflict of interest statement
R.C.K. has been a consultant for GlaxoSmithKline, Kaiser Permanente, Pfizer, Sanofi-Aventis, Shire Pharmaceuticals and Wyeth-Ayerst; has served on advisory boards for Eli Lilly & Co. and Wyeth-Ayerst; and has had research support for his epidemiological studies from Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson Pharmaceuticals, Ortho-McNeil Pharmaceuticals, Pfizer and Sanofi-Aventis.
Comment in
-
Cross-cultural attitudes to help-seeking among individuals who are suicidal: new perspective for policy-makers.Br J Psychiatry. 2011 Jul;199(1):8-10. doi: 10.1192/bjp.bp.110.087817. Br J Psychiatry. 2011. PMID: 21719875
References
-
- Hawton K, van Heeringen K. Suicide. Lancet 2009; 373: 1372– 81 - PubMed
-
- Murray CJ, Lopez AD. Evidence-based health policy: lessons from the Global Burden of Disease Study. Science 1996; 274: 740– 3 - PubMed
-
- Centers for Disease Control and Prevention Web-based Injury Statistics Query and Reporting System (WISQARS). CDC, 2010. (http://www.cdc.gov/injury/wisqars/index.html)
-
- World Health Organization WHO Resource Book on Mental Health, Human Rights, and Legislation. Dare to Care. WHO, 2005. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
